Masks of autoimmune hepatitis. Clinical observations
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 3
Abstract
Autoimmune hepatitis is a diagnosis of exclusion. Based on literature data, a third of patients are diagnosed with other autoimmune diseases, which are combined with AIH, which aggravates the severity of the disease and makes it difficult to diagnose. The AIH should be considered in case of any patient with acute or chronic liver disease, especially in the presence of hypergammaglobulinemia, and also if the patient has manifestations of other autoimmune diseases. The article presents clinical observations of patients with autoimmune liver disease. The development and course of the disease had masks, because it combined with other autoimmune diseases, such as vitiligo and primary biliary cholangitis. A feature of these cases is an atypical clinical manifestation of the disease. A long period of clinical well-being did not allow suspecting the presence of a pathology, which resulted in the presence of fibrosis and steatosis, but the presence of anti-LC1 antibodies allowed to diagnose AIH-2 and quickly assigning of pathogenetic therapy in the first clinical observation. The diagnosis was complicated by taking a biological active additives and the presence of vitiligo. The question of whether overlap-syndromes are independent diseases or are a variant of the AIH course, nowadays is still remain controversial, since the clinical manifestations of hepatitis are obligatory present in any of the variants of the overlap-syndrome. The data of the anamnesis and laboratory investigations of the second patient, which was under our supervision, showed the presence of pathology of the biliary tract and only detailed examination allowed us to confirm the presence of overlap-syndrome. Diagnosis of AIH and combined syndromes is a difficult task in the doctor’s clinical practice and requires a multidisciplinary approach. For this category of patients thorough examination and standardization of diagnostic criteria is necessary, because it will help in prompt diagnosis and adequate treatment of such severe patients.
Authors and Affiliations
L. V. Zhuravlyova, O. I. Tsivenko, О. V. Lakhno
Keywords
Related Articles
- EP ID EP615679
- DOI 10.30978/MG-2019-3-50
- Views 141
- Downloads 0
Human microbiome: general information and clinical significance of digestive canal eubiosis
The resent investigations demonstrate the key role of the human microbiome in the formation of homeostasis, highlight the microbiota effects on a human immune system, its development and physiology, including organo- and...
The results of multicenter study of efficacy of Helicobacter pylori eradication therapy, conducted according to the recommendations of Maastricht V Consensus Report
Objective — to study efficacy and safety of two weeks quadruple therapy with high doses of pantoprazole, bismuth subcitrate, clarithromycin, amoxicillin with concomitant adjuvant symbiotic therapy (Saccharomyces boulardi...
Sate of intestinal microbiome in patients with osteoarthritis
Objective — to study the composition of intestinal microflora (CM) in patients with osteoarthritis (OA) against the background of administration of non-steroidal anti-inflammatory drugs (NSAIDs) and without them, as well...
The dynamics of reactants and antiproteinases in the blood serum of patients with chronic pancreatitis
Objective — to study specific changes of the reactive proteins, synthesized in liver, and levels of antiproteinases in blood serum of patients with chronic pancreatitis. Materials and methods. Investigation involved 58...
Helicobacter pylori infection and acid-related diseases against the background of metabolic-associated conditions: mechanisms of development and management
The author presents data on the role of H. pylori infection in the initiation and progression of the changes in metabolic status of patients with type 2 diabetes mellitus (DM-2), insulin resistance, obesity, cardiovascul...